<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50153">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01750229</url>
  </required_header>
  <id_info>
    <org_study_id>1668</org_study_id>
    <nct_id>NCT01750229</nct_id>
  </id_info>
  <brief_title>Spinal Cord Stimulation Frequency Study</brief_title>
  <official_title>Randomized Controlled Double-blind Cross-over Trial Evaluating the Role of Frequencies on Spinal Cord Stimulation in the Management of Failed Back Surgery Syndrome (SCS Frequency Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MedtronicNeuro</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MedtronicNeuro</source>
  <oversight_info>
    <authority>United Kingdom: Medicines and Healthcare Products Regulatory Agency</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the role of frequency settings on spinal cord
      stimulation in the management of Failed Back Surgery Syndrome (SCS Frequency Study).
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Enrollment was temporarily suspended to align study materials with field safety notice.
  </why_stopped>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Visual Analog Pain Scale</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Failed Back Surgery Syndrome</condition>
  <arm_group>
    <arm_group_label>Medtronic RestoreSensor Frequency Setting 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Frequency Setting 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medtronic RestoreSensor Frequency Setting 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Frequency Setting 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medtronic RestoreSensor Frequency Setting 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Frequency Setting 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Medtronic RestoreSensor Frequency Setting 4</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Frequency Setting 4</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic RestoreSensor Frequency Setting 1</intervention_name>
    <description>Frequency Setting 1</description>
    <arm_group_label>Medtronic RestoreSensor Frequency Setting 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic RestoreSensor Frequency Setting 2</intervention_name>
    <description>Frequency Setting 2</description>
    <arm_group_label>Medtronic RestoreSensor Frequency Setting 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic RestoreSensor Frequency Setting 3</intervention_name>
    <description>Frequency Setting 3</description>
    <arm_group_label>Medtronic RestoreSensor Frequency Setting 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic RestoreSensor Frequency Setting 4</intervention_name>
    <description>Frequency Setting 4</description>
    <arm_group_label>Medtronic RestoreSensor Frequency Setting 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At least 18 years old at the time of informed consent

          -  Willing and able to provide a signed and dated informed consent

          -  Capable of comprehending and consenting in English

          -  Willing and able to comply with all study procedures, study visits, and be available
             for the duration of the study

          -  On a stable dose (no new, discontinued or changes in) of all prescribed pain
             medications and willing/able to maintain or only decrease the dose of all prescribed
             pain medications

          -  Tried appropriate conventional medical management for their pain

          -  Not indicated for additional surgical treatment in the opinion of the referring
             physician or spinal surgeon

          -  Undergone previous spinal surgery

          -  Diagnosed with FBSS with appropriate pain score

          -  Primary pain at appropriate spinal level

        Exclusion Criteria:

          -  Has an active implanted device, whether turned on or off

          -  Displays current signs of a systemic infection

          -  Pregnant or lactating, inadequate birth control, or the possibility of pregnancy
             during the study

          -  Has untreated major psychiatric comorbidity

          -  Has serious drug-related behavioral issues

          -  Has neurological abnormalities unrelated to Failed Back Surgery Syndrome

          -  Diagnosed with Raynaud disease

          -  Diagnosed with Fibromyalgia

          -  Has any active malignancy or has been diagnosed with cancer and has not been in
             remission for at least 1 year prior to screening

          -  Has secondary gains which, in the opinion of the investigator, are likely to
             interfere with the study

          -  Participating or planning to participate in another clinical trial

          -  Has characteristics/limits of household or close contacts involved in study (eg,
             family member already a study participant where blind could be broken)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adnan Al-Kaisy, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guy's and St Thomas' NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Guy's and St. Thomas' NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 18, 2014</lastchanged_date>
  <firstreceived_date>November 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Failed Back Surgery Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
